SCHEMBL9765025

SCHEMBL9765025

CC(C)c1cccc(C(C)C)c1NC(=O)N(Cc1ccccc1)CC(c1ccccc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.49
SOAT1 P35610 1/20 0.49
UBE2M P61081 1/20 0.48
DCUN1D1 Q96GG9 1/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 1/20 0.48
ALDH1A1 P00352 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CASR P41180 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11143056 0.90 ALDH1A1 (0.58) SOAT2SOAT1UBE2MDCUN1D1KMT2A
SCHEMBL9192201 0.85 ALDH1A1 (0.49) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL6804058 0.83 SOAT2 (0.49) SOAT2SOAT1UBE2MDCUN1D1KMT2A
SCHEMBL9723419 0.80 SOAT2 (0.51) SOAT2SOAT1KMT2ALMNAALDH1A1
SCHEMBL9679390 0.78 ALDH1A1 (0.58) SOAT2SOAT1KMT2ALMNAALDH1A1
SCHEMBL855625 0.78 SOAT2 (0.52) SOAT2SOAT1UBE2MDCUN1D1KMT2A
SCHEMBL6899771 0.78 SOAT1 (0.62) SOAT2SOAT1UBE2MDCUN1D1KMT2A
SCHEMBL6802990 0.77 KMT2A (0.50) SOAT2SOAT1KMT2ALMNAMEN1
SCHEMBL9765050 0.76 SOAT1 (0.51) SOAT2SOAT1UBE2MDCUN1D1KMT2A
SCHEMBL9681145 0.76 SOAT2 (0.56) SOAT2SOAT1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994465-A Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds WARNER-LAMBERT COMPANY (US) 1991-02-19 US disclosed
EP-0384320-A1 Antihyperlipidemic and anti-atherosclerotic trisubstituted urea compounds WARNER-LAMBERT COMPANY (US) 1990-08-29 EP disclosed